<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: A transcription regulatory complex (TRC) that includes Ets1, Ets2, PEA3 and Î²-catenin/T-cell factors regulates osteopontin (OPN) that is implicated in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>) dissemination </plain></SENT>
<SENT sid="1" pm="."><plain>The consistency of OPN transcriptional control between primary <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> and <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastases</z:e> is unclear </plain></SENT>
<SENT sid="2" pm="."><plain>This study investigates expression and prognostic significance of the OPN-TRC in primary human <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> and associated colorectal <z:e sem="disease" ids="C0494165" disease_type="Neoplastic Process" abbrv="">liver metastases</z:e> (CRLM) </plain></SENT>
<SENT sid="3" pm="."><plain>METHODS: Osteopontin-TRC factors were assayed by digital microscopy in 38 primary <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRCs</z:e> and matched CRLM specimens and assessed against clinical prognosis </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: In primary <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>, OPN expression intensity correlated with that of its co-activators, PEA3 (r=0.600; P&lt;0.01), Ets1 (r=0.552; P&lt;0.01), Ets2 (r=0.521; P&lt;0.01) and had prognostic significance </plain></SENT>
<SENT sid="5" pm="."><plain>Osteopontin intensity in primary <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> inversely correlated with the interval between diagnosis and resection of CRLM </plain></SENT>
<SENT sid="6" pm="."><plain>Overall OPN intensity was lower in CRLM than primary <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> and correlations with co-activators were weaker, for example, Ets1 (P=0.047), PEA3 (P=0.022) or nonsignificant (Ets2) </plain></SENT>
<SENT sid="7" pm="."><plain>The ratio of OPN expression in CRLM vs primary <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> had prognostic significance </plain></SENT>
<SENT sid="8" pm="."><plain>CONCLUSION: This study supports transcriptional control of OPN by known coregulators in both primary and secondary <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> </plain></SENT>
<SENT sid="9" pm="."><plain>Weaker associations in CRLM suggest involvement of other unknown factors possibly from the liver microenvironment or resulting from additional genetic or epigenetic changes that drive <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> metastatic capability in OPN transcriptional control </plain></SENT>
</text></document>